1. |
Liu Y, Wang Y, Zhao K, et al. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study. BMC Cancer, 2020, 20(1): 181. doi: 10.1186/s12885-020-6675-0.
|
2. |
Zhou SL, Guo YP, Zhang L, et al. Predicting factors of central lymph node metastasis and BRAFV600E mutation in Chinese population with papillary thyroid carcinoma. World J Surg Oncol, 2021, 19(1): 211. doi: 10.1186/s12957-021-02326-y.
|
3. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
|
4. |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021. 肿瘤预防与治疗, 2021, 34(12): 1164-1200.
|
5. |
Lallemant B, Reynaud C, Alovisetti C, et al. Updated definition of level Ⅵ lymph node classification in the neck. Acta Otolaryngol, 2007, 127(3): 318-322.
|
6. |
Zhou T, Wu F, Zhao L, et al. A meta-analysis of risk factors for lymph node posterior to the right recurrent laryngeal nerve metastasis in papillary thyroid carcinoma. Gland Surg, 2021, 10(6): 1841-1851.
|
7. |
张浩, 孙威. 颈淋巴结清扫术易遗漏转移淋巴结部位及其对策. 中国实用外科杂志, 2017, 37(9): 965-970.
|
8. |
中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版). 中华普通外科学文献(电子版), 2019, 13(1): 1-15.
|
9. |
孙一心, 王朝晖, 陈锦, 等. 甲状腺乳头状癌右侧喉返神经深方淋巴结转移危险因素分析. 中国实用外科杂志, 2023, 43(6): 708-713.
|
10. |
Wang Z, Chang Q, Zhang H, et al. A clinical predictive model of central lymph node metastases in papillary thyroid carcinoma. Front Endocrinol (Lausanne), 2022, 13: 856278. doi: 10.3389/fendo.2022.856278.
|
11. |
Diessl S, Holzberger B, Mäder U, et al. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf), 2012, 76(4): 586-592.
|
12. |
王慧芳, 于博, 赵文君, 等. cN0甲状腺微小乳头状癌右侧喉返神经后方淋巴结转移及清扫研究进展. 中国普通外科杂志, 2020, 29(5): 603-610.
|
13. |
Li J, He G, Tong Y, et al. A novel scoring system for the risk of papillary thyroid cancer metastases in lymph nodes posterior to the right of the recurrent laryngeal nerve. Endocr Pract, 2021, 27(1): 15-20.
|
14. |
Kim D, Kwon HK, Shin SC, et al. Right posterior paratracheal lymph nodes metastasis is one of the predictive factors in right-sided papillary thyroid carcinoma. Surgery, 2019, 166(6): 1154-1159.
|
15. |
朱一鸣, 刘绍严. 甲状腺癌术后复发再手术难点与对策. 中国实用外科杂志, 2021, 41(8): 856-860.
|
16. |
关淯夫. cN0期甲状腺乳头状癌右侧喉返神经背侧淋巴结转移相关危险因素分析. 大连医科大学, 2020.
|
17. |
Chen F, Jin Y, Feng L, et al. RRS1 gene expression involved in the progression of papillary thyroid carcinoma. Cancer Cell Int, 2018, 18: 20. doi: 10.1186/s12935-018-0519-x.
|
18. |
Luo Y, Xu XC, Shen J, et al. Model of lymph node metastasis posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma. Cancer Manag Res, 2018, 10: 2449-2455.
|
19. |
万福强, 安玉胜, 任忠峰, 等. 右喉返神经后方淋巴结清扫在cN0期甲状腺乳头状微小癌手术中的探讨. 中国综合临床, 2017, 33(11): 981-984.
|
20. |
彭冬梅, 晏晨, 苏安平, 等. cN0甲状腺微小乳头状癌右侧喉返神经浅面及深面淋巴结转移危险因素分析. 中国实用外科杂志, 2016, 36(5): 547-551.
|
21. |
刘文, 程若川, 苏艳军, 等. 甲状腺微小乳头状癌rⅥb区转移预测因素及rⅥa区、rⅥb区转移相关性研究. 中国实用外科杂志, 2017, 37(9): 1007-1012.
|
22. |
Hou J, Shan H, Zhang Y, et al. Risk factors of metastasis to the lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma. Eur Arch Otorhinolaryngol, 2020, 277(3): 881-886.
|
23. |
陈宏存, 李良, 江鸣, 等. 甲状腺乳头状癌右侧喉返神经后方淋巴结转移的相关因素分析及其临床意义. 国际肿瘤学杂志, 2018, 45(7): 391-394.
|
24. |
程鸣鸣, 柴芳, 张晓明. 甲状腺乳头状癌右侧喉返神经深层(Ⅵb区)淋巴结转移的风险分析. 中国现代医学杂志, 2022, 32(1): 85-90.
|
25. |
Zhang DG, Gao L, Miao YW, et al. Risk factors for posterior to right recurrent laryngeal nerve lymph node metastasis in papillary thyroid carcinoma. Saudi Med J, 2014, 35(8): 832-837.
|
26. |
孙振华, 赵志泓, 蒋华平. 甲状腺微小乳头状癌rⅥb区淋巴结转移因素分析及术中纳米碳应用价值研究. 临床耳鼻咽喉头颈外科杂志, 2020, 34(4): 355-359.
|